Frontiers in Aging Neuroscience (Apr 2021)
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline
- Niels Hansen,
- Niels Hansen,
- Aditya Singh,
- Aditya Singh,
- Claudia Bartels,
- Frederic Brosseron,
- Frederic Brosseron,
- Katharina Buerger,
- Katharina Buerger,
- Arda C. Cetindag,
- Arda C. Cetindag,
- Laura Dobisch,
- Peter Dechent,
- Birgit B. Ertl-Wagner,
- Klaus Fliessbach,
- Klaus Fliessbach,
- John D. Haynes,
- Michael T. Heneka,
- Michael T. Heneka,
- Daniel Janowitz,
- Ingo Kilimann,
- Ingo Kilimann,
- Christoph Laske,
- Christoph Laske,
- Christoph Laske,
- Coraline D. Metzger,
- Coraline D. Metzger,
- Coraline D. Metzger,
- Matthias H. Munk,
- Matthias H. Munk,
- Matthias H. Munk,
- Oliver Peters,
- Oliver Peters,
- Josef Priller,
- Josef Priller,
- Nina Roy,
- Klaus Scheffler,
- Anja Schneider,
- Anja Schneider,
- Annika Spottke,
- Annika Spottke,
- Eike J. Spruth,
- Eike J. Spruth,
- Stefan Teipel,
- Stefan Teipel,
- Maike Tscheuschler,
- Ruth Vukovich,
- Jens Wiltfang,
- Jens Wiltfang,
- Jens Wiltfang,
- Emrah Duezel,
- Emrah Duezel,
- Frank Jessen,
- Frank Jessen,
- Roberto Goya-Maldonado,
- Roberto Goya-Maldonado
Affiliations
- Niels Hansen
- Department of Psychiatry and Psychotherapy, Göttingen, Germany
- Niels Hansen
- Laboratory of Systems Neuroscience and Imaging in Psychiatry, University Medical Center Göttingen, Göttingen, Germany
- Aditya Singh
- Department of Psychiatry and Psychotherapy, Göttingen, Germany
- Aditya Singh
- Laboratory of Systems Neuroscience and Imaging in Psychiatry, University Medical Center Göttingen, Göttingen, Germany
- Claudia Bartels
- Department of Psychiatry and Psychotherapy, Göttingen, Germany
- Frederic Brosseron
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Frederic Brosseron
- Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
- Katharina Buerger
- German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
- Katharina Buerger
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
- Arda C. Cetindag
- Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
- Arda C. Cetindag
- German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
- Laura Dobisch
- German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
- Peter Dechent
- 0MR-Research in Neurology and Psychiatry, University Medical Center Göttingen, Göttingen, Germany
- Birgit B. Ertl-Wagner
- 1Institute for Clinical Radiology, Ludwig-Maximilians-University, Munich, Germany
- Klaus Fliessbach
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Klaus Fliessbach
- Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
- John D. Haynes
- 2Bernstein Center for Computational Neuroscience, Charité—Universitätsmedizin, Berlin, Germany
- Michael T. Heneka
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Michael T. Heneka
- Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
- Daniel Janowitz
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
- Ingo Kilimann
- 3German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany
- Ingo Kilimann
- 4Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany
- Christoph Laske
- 5German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
- Christoph Laske
- 6Section for Dementia Research, Hertie Institute for Clinical Brain Research, Tübingen, Germany
- Christoph Laske
- 7Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany
- Coraline D. Metzger
- German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
- Coraline D. Metzger
- 8Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany
- Coraline D. Metzger
- 9Department of Psychiatry and Psychotherapy, Otto-von-Guericke University, Magdeburg, Germany
- Matthias H. Munk
- 5German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
- Matthias H. Munk
- 6Section for Dementia Research, Hertie Institute for Clinical Brain Research, Tübingen, Germany
- Matthias H. Munk
- 7Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany
- Oliver Peters
- Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
- Oliver Peters
- German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
- Josef Priller
- German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
- Josef Priller
- 0Department of Psychiatry and Psychotherapy, Berlin, Germany
- Nina Roy
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Klaus Scheffler
- 1Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany
- Anja Schneider
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Anja Schneider
- Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
- Annika Spottke
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Annika Spottke
- 2Department of Neurology, University of Bonn, Bonn, Germany
- Eike J. Spruth
- German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
- Eike J. Spruth
- 0Department of Psychiatry and Psychotherapy, Berlin, Germany
- Stefan Teipel
- 3German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany
- Stefan Teipel
- 4Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany
- Maike Tscheuschler
- 3Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, Cologne, Germany
- Ruth Vukovich
- Department of Psychiatry and Psychotherapy, Göttingen, Germany
- Jens Wiltfang
- Department of Psychiatry and Psychotherapy, Göttingen, Germany
- Jens Wiltfang
- 4German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
- Jens Wiltfang
- 5Neurosciences and Signaling Group, Department of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal
- Emrah Duezel
- German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
- Emrah Duezel
- 8Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany
- Frank Jessen
- 3Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, Cologne, Germany
- Frank Jessen
- 6Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Köln, Germany
- Roberto Goya-Maldonado
- Department of Psychiatry and Psychotherapy, Göttingen, Germany
- Roberto Goya-Maldonado
- Laboratory of Systems Neuroscience and Imaging in Psychiatry, University Medical Center Göttingen, Göttingen, Germany
- DOI
- https://doi.org/10.3389/fnagi.2021.626974
- Journal volume & issue
-
Vol. 13
Abstract
Background: The hippocampus and its subfields (HippSub) are reported to be diminished in patients with Alzheimer's disease (AD), bipolar disorder (BD), and major depressive disorder (MDD). We examined these groups vs healthy controls (HC) to reveal HippSub alterations between diseases.Methods: We segmented 3T-MRI T2-weighted hippocampal images of 67 HC, 58 BD, and MDD patients from the AFFDIS study and 137 patients from the DELCODE study assessing cognitive decline, including subjective cognitive decline (SCD), amnestic mild cognitive impairment (aMCI), and AD, via Free Surfer 6.0 to compare volumes across groups.Results: Groups differed significantly in several HippSub volumes, particularly between patients with AD and mood disorders. In comparison to HC, significant lower volumes appear in aMCI and AD groups in specific subfields. Smaller volumes in the left presubiculum are detected in aMCI and AD patients, differing from the BD group. A significant linear regression is seen between left hippocampus volume and duration since the first depressive episode.Conclusions: HippSub volume alterations were observed in AD, but not in early-onset MDD and BD, reinforcing the notion of different neural mechanisms in hippocampal degeneration. Moreover, duration since the first depressive episode was a relevant factor explaining the lower left hippocampal volumes present in groups.
Keywords
- Alzheimer's disease
- cognitive impairment
- early-onset depression
- hippocampus
- hippocampal subfields
- MRI volumetry